[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UA99716C2 - Antibody that specifically binds to human il-17 receptor a (il-17ra) - Google Patents

Antibody that specifically binds to human il-17 receptor a (il-17ra)

Info

Publication number
UA99716C2
UA99716C2 UAA200904215A UAA200904215A UA99716C2 UA 99716 C2 UA99716 C2 UA 99716C2 UA A200904215 A UAA200904215 A UA A200904215A UA A200904215 A UAA200904215 A UA A200904215A UA 99716 C2 UA99716 C2 UA 99716C2
Authority
UA
Ukraine
Prior art keywords
antibody
receptor
human
specifically binds
relates
Prior art date
Application number
UAA200904215A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джоэл Токер
Жак Дж. Пешон
Давид Фитцпатрик
Джеймс Ф. Смозерс
Кристофер Мехлин
Ай Чинг Лим
Original Assignee
Кирин-Амген Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кирин-Амген Инк. filed Critical Кирин-Амген Инк.
Publication of UA99716C2 publication Critical patent/UA99716C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to an isolated antibody that specifically binds to human IL-17 receptor A (IL-17RA), a polynucleotide encoding the antibody, plasmide, host cell, method for making the antibody. The invention further relates to a pharmaceutical composition comprising the antibody and use of the antibody methods for treating diseases mediated by IL-17.
UAA200904215A 2006-10-02 2007-10-01 Antibody that specifically binds to human il-17 receptor a (il-17ra) UA99716C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82788206P 2006-10-02 2006-10-02

Publications (1)

Publication Number Publication Date
UA99716C2 true UA99716C2 (en) 2012-09-25

Family

ID=41124103

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200904215A UA99716C2 (en) 2006-10-02 2007-10-01 Antibody that specifically binds to human il-17 receptor a (il-17ra)

Country Status (5)

Country Link
CN (1) CN101541833B (en)
JO (1) JO2991B1 (en)
NO (1) NO20200595A1 (en)
UA (1) UA99716C2 (en)
ZA (1) ZA200902018B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011088120A1 (en) * 2010-01-15 2011-07-21 Amgen Inc. Antibody formulation and therapeutic regimens
ES3030036T3 (en) * 2010-11-05 2025-06-26 Novartis Ag Pharmaceutical compositions comprising secukinumab
SG11201607881SA (en) * 2014-03-31 2016-10-28 Kirin Amgen Inc Methods of treating nail and scalp psoriasis
JP6663910B2 (en) * 2014-08-26 2020-03-13 アムジェン ケー・エー，インコーポレイテッド Method for treating psoriatic patients receiving anti-TNF-α antibody therapy
CN110003337B (en) * 2019-04-12 2023-05-09 深圳普瑞金生物药业股份有限公司 IL17RA single domain antibody, nucleic acid and kit
CN112891531B (en) * 2020-06-19 2021-10-08 北京东方百泰生物科技股份有限公司 Injection preparation of anti-IL-17 RA monoclonal antibody
CN111848795B (en) * 2020-06-19 2021-03-12 北京东方百泰生物科技股份有限公司 anti-IL-17 RA monoclonal antibody and application thereof
CN113150148B (en) * 2020-06-19 2021-10-08 北京东方百泰生物科技股份有限公司 Purification method of anti-IL-17 RA monoclonal antibody
CN113896793B (en) * 2021-09-30 2023-05-26 港科鹏禾生物(苏州)有限公司 Monoclonal antibody for resisting human IL-17RC and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2596986A1 (en) * 2005-02-14 2006-08-24 Wyeth Use of il-17f in diagnosis and therapy of airway inflammation

Also Published As

Publication number Publication date
JO2991B1 (en) 2016-09-05
CN101541833A (en) 2009-09-23
NO20200595A1 (en) 2009-06-30
ZA200902018B (en) 2010-07-28
CN101541833B (en) 2014-01-29

Similar Documents

Publication Publication Date Title
UA99716C2 (en) Antibody that specifically binds to human il-17 receptor a (il-17ra)
JO2576B1 (en) Antibodies
NZ591098A (en) Engineered anti-il-13 antibodies, compositions, methods and uses
UA96279C2 (en) Isolated antibody or fragment thereof that is capable of binding to human nogo
CA2813849C (en) Secukinumab for use in the treatment of ankylosing spondylitis
MX2009003511A (en) Il-17 receptor a antigen binding proteins.
TN2011000528A1 (en) Compositions and methods for antibodies targeting complement protein c3b
WO2010010551A3 (en) Angiopoietin derived peptides
UA95478C2 (en) Humanized c-kit antibody
UA102867C2 (en) Anti cxcr4 antibodies and their use for the treatment of cancer
MX353319B (en) Compositions and methods relating to glucagon receptor antibodies.
MY159630A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
MY156315A (en) Anti-vegf antibodies
MY151191A (en) Novel antibodies
MX2009013194A (en) Page fusion proteins.
MX2013007067A (en) Anti-il-18 antibodies and their uses.
MY145349A (en) Benzofuro- and benzothienopyrimidine modulators of the histamine h4 receptor
UA106890C2 (en) LibreOfficeantibody to CDCP1
UA99633C2 (en) Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof
WO2011038933A3 (en) Anti-hsv antibody
WO2008027739A3 (en) Antibodies to ntb-a
UA113623C2 (en) TISSUE FACTOR FACTOR (TFPI) MONOCLONAL ANTIBODY AGAINST TISSUE FACTOR INHIBITOR
MX364623B (en) MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO.
WO2007064727A3 (en) Penetrabodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases
UA105384C2 (en) Treatment of insulin-resistant disorders